Abstract:The endogenous FGF21 level is a potential target for diagnosing NAFLD. This study aimed to assess the clinical utility of FGF21 in diagnosing NAFLD and provide new ideas for predicting and preventing NAFLD. A total of 193 patients diagnosed with NAFLD based on diagnostic criteria and 64 healthy individuals were included in the NAFLD and non-NAFLD groups, respectively. Data on the participant names, sex, age, height, weight, blood pressure, serum FGF21 levels, liver function enzyme (AST, ALT, ALP, and GGT) levels, lipid profile (TC, TG, HDL-C, and LDL-C) indicators, and blood glucose levels were collected. The data were statistically analyzed to assess the correlations between serum FGF21 levels and related biochemical markers in NAFLD patients. The areas under the receiver operating characteristic curves (AUCs) of serum FGF21, lipids (TG + TC + HDL + LDL), and FGF21 combined with lipids for the diagnosis of NAFLD were compared. Compared with the non-NAFLD group, the NAFLD group presented significantly higher levels of FGF21. Serum FGF21 levels in the NAFLD group were positively correlated with the TG, TC, and LDL-C levels ( P < 0.05). The area under the receiver operating characteristic curve (AUC) of serum FGF21 for the diagnosis of NAFLD was 0.832 (95% CI: 0.77–0.886, P < 0.001). The AUC of FGF21 combined with lipids (TG + TC + HDL + LDL) for the diagnosis of NAFLD was 0.910 (95% CI: 0.874–0.946, P < 0.001). There is a close association between elevated FGF21 levels and the development of NAFLD. The progression of NAFLD is complex and varied, and its pathogenesis is unclear. Early detection, prevention, and intervention may help slow NAFLD development or even reverse the disease. In this study, we found that the FGF21 level could be used as an auxiliary biological indicator for predicting NAFLD, and the role of FGF21 in the progression of NAFLD deserves to be investigated in the future.

FGF-21: Promising Biomarker for Detecting Ketosis in Dairy Cows.

Changes in Selected Biochemical Parameters During Subclinical and Clinical Ketosis in Dairy Cows

High Circulating Fibroblast Growth Factor-21 Levels as a Prognostic Marker in Fatty Pancreas Patients

High circulating fibroblast growth factor-21 levels as a screening marker in fatty pancreas patients

The relationship between Fibroblast Growth Factor-21 and characteristic parameters related to energy balance in dairy cows

Critical Thresholds of Liver Function Parameters for Ketosis Prediction in Dairy Cows Using Receiver Operating Characteristic (ROC) Analysis

Effects of Exogenous Fibroblast Growth Factor-21 on Characteristic Parameters Related to Energy Metabolism in Dairy Cows

Clinical significance of serum FGF21 levels in diagnosing nonalcoholic fatty liver disease early

FGF21 Reduces Lipid Accumulation in Bovine Hepatocytes by Enhancing Lipid Oxidation and Reducing Lipogenesis via AMPK Signaling

Predictive Value of Plasma Parameters in the Risk of Postpartum Ketosis in Dairy Cows

High Serum Level of Fibroblast Growth Factor 21 is an Independent Predictor of Non-Alcoholic Fatty Liver Disease: A 3-Year Prospective Study in China

Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional Study

Fibroblast growth factor 21 in dairy cows: current knowledge and potential relevance

Serum FGF21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hsCRP levels independently.

Performance and Metabolic, Inflammatory, and Oxidative Stress-Related Parameters in Early Lactating Dairy Cows with High and Low Hepatic FGF21 Expression

Study on early diagnosis of fatty liver in lactating dairy cows

Serum FGF-21 levels in type 2 diabetic patients.

Fibroblast Growth Factor 21 Levels Are Increased in Nonalcoholic Fatty Liver Disease Patients and Are Correlated with Hepatic Triglyceride

High Non-Esterified Fatty Acid Concentrations Promote Expression and Secretion of Fibroblast Growth Factor 21 in Calf Hepatocytes Cultured in Vitro.

Research on the Serum Selected Biochemical Indicator Metaboilic Level in Dairy Cows with Subclinical Ketosis

Ketotic Cows Display a Different Serum Nonesterified Fatty Acid Composition